[Review on the etiology and treatment of bacterial pneumonias].
The bacterial pneumoniae are the significant factor of morbidity and mortality all over the world. So USA are at the sixth place per mortality cause. The bacteria are in 60-80% of cases the causes of pneumonia in the communities. Therefore this is the review on the ethiology of the verification and treatment of pneumonias in the 17-month period in the General hospital "Sarajevo". In the period of the 1st January 2002 till the 31st May 2003 year, it was examined 105 sputa on the antibiogram, and in 12 cases (11.4%) was found the positive bacterial finding. Most often were gram negative bacteria in 7 cases (58.3%), while were found the gram positive in 5 patients (41.7%). Therefore that the majority of the examinees belonged to the risk group, and that were the patients with over 50 years of age 11 (78.6%), with the chronic obstructive lung disease 5 (35.7%), with the malignant disease 1 (7.1%) and with the coinfection of the urinary tract. E. coli was found in 3 patient (25.0%), Kl. Pneumoniae in 2 (16.7%), Ps. aeruginosis in 1 (8.3%), Citrobacter freundi in 1 (8.3%), and in 2 cases (16.7%) were isolated. Staphylococcus intermedius and Streptococcus beta haemolyticus gr. A and Str. Pneumoniae in 1 case (8.3%). To the patients with the positive finding of sputum on antibiogram were most often administered empirically cefalosporia of the third generation because it was about the more severe patients, then the combination of ampicillin with gentamicin. All were dismissed as recovered or in better condition. Pneumonias is in the risk groups are possible to prevent to the five-years pneumococcus vaccine when is indicated or by influenza vaccine when simultaneously was prevented the viral, that is the possible bacterially superinfected pneumonia.
Hrabac
Nina
N
Opća bolnica Sarajevo, Bosna i Hercegovina.
Agić
Sarija
S
Jazić
Sead
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology*; D012307:Risk Factors
D000900:Anti-Bacterial Agents